Exchange Traded Concepts’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$56.5M Sell
47,128
-1,836
-4% -$1.88M 0.26% 66
2026
Q1
$45M Buy
48,964
+21,904
+81% +$22.2M 0.32% 59
2025
Q4
$29.1M Buy
27,060
+13,957
+107% +$13.3M 0.22% 90
2025
Q3
$10M Sell
13,103
-12,137
-48% -$9.03M 0.09% 240
2025
Q2
$19.7M Buy
25,240
+2,284
+10% +$1.77M 0.24% 97
2025
Q1
$19M Sell
22,956
-15,854
-41% -$13.2M 0.32% 63
2024
Q4
$30M Buy
38,810
+4,733
+14% +$3.92M 0.6% 25
2024
Q3
$30.2M Buy
34,077
+2,781
+9% +$2.5M 0.71% 22
2024
Q2
$28.3M Buy
31,296
+29,315
+1,480% +$23.4M 0.72% 23
2024
Q1
$1.54M Sell
1,981
-41,115
-95% -$29.3M 0.04% 334
2023
Q4
$25.1M Buy
43,096
+2,851
+7% +$1.66M 0.67% 34
2023
Q3
$21.6M Sell
40,245
-9,540
-19% -$4.92M 0.61% 27
2023
Q2
$23.3M Sell
49,785
-17,918
-26% -$7.51M 0.58% 38
2023
Q1
$23.3M Buy
67,703
+31,058
+85% +$10.5M 0.64% 15
2022
Q4
$13.4M Sell
36,645
-2,543
-6% -$902K 0.38% 50
2022
Q3
$12.7M Sell
39,188
-583
-1% -$185K 0.41% 21
2022
Q2
$12.9M Buy
39,771
+39,566
+19,300% +$11.9M 0.38% 36
2022
Q1
$59K Sell
205
-66,369
-100% -$17.1M ﹤0.01% 910
2021
Q4
$18.4M Buy
66,574
+739
+1% +$187K 0.36% 41
2021
Q3
$15.2M Buy
65,835
+11,684
+22% +$2.88M 0.39% 33
2021
Q2
$12.4M Buy
54,151
+7,609
+16% +$1.53M 0.39% 39
2021
Q1
$8.7M Sell
46,542
-16,441
-26% -$3.22M 0.33% 54
2020
Q4
$10.6M Sell
62,983
-8,467
-12% -$1.26M 0.49% 25
2020
Q3
$10.6M Buy
71,450
+4,185
+6% +$648K 0.6% 24
2020
Q2
$11M Buy
67,265
+63,951
+1,930% +$9.82M 1.83% 2
2020
Q1
$460K Buy
3,314
+15
+0.5% +$2.06K 0.25% 123
2019
Q4
$434K Buy
+3,299
New +$382K 0.09% 131

Other funds holding LLY

Exchange Traded Concepts's LLY Position: Q2 2026 in Review

Exchange Traded Concepts reduced its Eli Lilly (LLY) stake by 3.7% in Q2 2026, selling an estimated $1.88M and leaving 47,128 shares worth $56.5M. The position accounts for 0.26% of the portfolio, ranked #66.

Exchange Traded Concepts first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. 1,233 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Exchange Traded Concepts held 47,128 shares of Eli Lilly worth $56.5M as of Q2 2026.
  • Exchange Traded Concepts sold 1,836 Eli Lilly shares in Q2 2026, an estimated $1.88M.
  • Eli Lilly made up 0.26% of Exchange Traded Concepts's portfolio in Q2 2026, its #66 holding.
  • Exchange Traded Concepts first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • 1,233 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.